NPs Basic Information

Name
Ergosterol peroxide
Molecular Formula C28H44O3
IUPAC Name*
(1S,2R,5R,6R,9R,10R,13S,15S)-5-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.01,9.02,6.010,15]nonadec-18-en-13-ol
SMILES
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@]24C=C[C@@]5([C@@]3(CC[C@@H](C5)O)C)OO4)C
InChI
InChI=1S/C28H44O3/c1-18(2)19(3)7-8-20(4)22-9-10-23-25(22,5)13-12-24-26(6)14-11-21(29)17-27(26)15-16-28(23,24)31-30-27/h7-8,15-16,18-24,29H,9-14,17H2,1-6H3/b8-7+/t19-,20+,21-,22+,23+,24+,25+,26+,27+,28-/m0/s1
InChIKey
VXOZCESVZIRHCJ-KGHQQZOUSA-N
Synonyms
Ergosterol peroxide; Ergosterol endoperoxide; Ergosterol-5,8-peroxide; Peroxyergosterol; 2061-64-5; Ergosterol 5alpha,8alpha-epidioxide; UG9TN81TGH; CHEMBL434750; CHEBI:65858; 5alpha,8alpha-epidioxyergosta-6,22-dien-3beta-ol; NSC31324; NSC-31324; (1S,2R,5R,6R,9R,10R,13S,15S)-5-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.01,9.02,6.010,15]nonadec-18-en-13-ol; 5alpha,8alpha-epidioxy-22E-ergosta-6,22-dien-3beta-ol; (22E,24R)-5alpha,8alpha-epidioxyergosta-6,22-dien-3beta-ol; (24R)-5alpha,8alpha-epidioxy-24-methylcholesta-6,22-dien-3beta-ol; NSC 31324; (3S,5S,8S,9R,10R,13R,14R,17R)-17-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-2H-5,8-epidioxycyclopenta[a]phenanthren-3-ol; UNII-UG9TN81TGH; (3beta,5alpha,8alpha,22E)-5,8-epidioxyergosta-6,22-dien-3-ol; 5.alpha.,8.alpha.-Ergosta-6,22-dien-3.beta.-ol, 5,8-epidioxy-; Ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22E)-; Ergosterol 5.alpha.,8.alpha.-epidioxide; Ergosterol 5-alpha,8-alpha-epidioxide; BRN 0096852; ERGOSTERYL PEROXIDE; 5-19-03-00043 (Beilstein Handbook Reference); Ergosterol Peroxide_120246; SCHEMBL3281353; ERGOSTEROL 5,8-PEROXIDE; 5,8-Epidioxy-5-alpha,8-alpha-ergosta-6,22-dien-3-beta-ol; DTXSID501021533; HY-N3845; BDBM50334064; ZINC38139718; ERGOSTEROL ENDOPEROXIDE [INCI]; CS-0024320; 5.ALPHA.,8.ALPHA.-EPIDIOXYERGOSTEROL; 5.alpha.,22-dien-3.beta.-ol, 5,8-epidioxy-; 5alpha,8alpha-Epidioxyergosta-6,22-diene-3beta-ol; Q5385831; 5-alpha,8-alpha-ERGOSTA-6,22-DIEN-3-beta-OL, 5,8-EPIDIOXY-; Ergosta-6, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22E)-; (22E)-5.ALPHA.,8.ALPHA.-EPIDIOXYERGOSTA-6,22-DIEN-3.BETA.-OL; (24R)-ERGOST-5.ALPHA.,8.ALPHA.-EPIDIOXY-6,22-DIEN-3.BETA.-OL; 3.BETA.-HYDROXY-5.ALPHA.,8.ALPHA.-EPIDIOXYERGOSTA-6,22-DIENE; Ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3-beta,5-alpha,8-alpha,22E)-; Ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3beta,5alpha,8alpha,22E)-; (22E,24R)-5.ALPHA.,8.ALPHA.-EPIDIOXYERGOSTA-6,22-DIEN-3.BETA.-OL; 5.ALPHA.,8.ALPHA.-EPIDOXY-(22E,24R)-ERGOSTA-6,22-DIEN-3.BETA.-OL; (1S,2R,5R,6R,9R,10R,13S,15S)-5-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.0^{1,9}.0^{2,6}.0^{10,15}]nonadec-18-en-13-ol
CAS 2061-64-5
PubChem CID 5351516
ChEMBL ID CHEMBL434750
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Steroids and steroid deri
        • Subclass: Ergostane steroids
          • Direct Parent: Ergostane steroids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 428.6 ALogp: 6.7
HBD: 1 HBA: 3
Rotatable Bonds: 4 Lipinski's rule of five: Rejected
Polar Surface Area: 38.7 Aromatic Rings: 6
Heavy Atoms: 31 QED Weighted: 0.414

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.849 MDCK Permeability: 0.00001820
Pgp-inhibitor: 0.002 Pgp-substrate: 0.663
Human Intestinal Absorption (HIA): 0.007 20% Bioavailability (F20%): 0.027
30% Bioavailability (F30%): 0.038

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.066 Plasma Protein Binding (PPB): 90.01%
Volume Distribution (VD): 1.146 Fu: 2.06%

ADMET: Metabolism

CYP1A2-inhibitor: 0.035 CYP1A2-substrate: 0.954
CYP2C19-inhibitor: 0.078 CYP2C19-substrate: 0.95
CYP2C9-inhibitor: 0.265 CYP2C9-substrate: 0.034
CYP2D6-inhibitor: 0.026 CYP2D6-substrate: 0.142
CYP3A4-inhibitor: 0.915 CYP3A4-substrate: 0.929

ADMET: Excretion

Clearance (CL): 3.268 Half-life (T1/2): 0.123

ADMET: Toxicity

hERG Blockers: 0.78 Human Hepatotoxicity (H-HT): 0.891
Drug-inuced Liver Injury (DILI): 0.012 AMES Toxicity: 0.003
Rat Oral Acute Toxicity: 0.778 Maximum Recommended Daily Dose: 0.985
Skin Sensitization: 0.345 Carcinogencity: 0.011
Eye Corrosion: 0.006 Eye Irritation: 0.047
Respiratory Toxicity: 0.983
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC004740 1.000 D0G8OC 0.431
ENC005015 1.000 D06JPB 0.395
ENC005013 1.000 D0G5CF 0.388
ENC005779 1.000 D0Y7LD 0.341
ENC004858 0.794 D0N1TP 0.302
ENC002327 0.700 D01QUS 0.280
ENC004857 0.654 D0G3SH 0.264
ENC005014 0.654 D03ZTE 0.264
ENC004030 0.654 D0M4WA 0.263
ENC006034 0.579 D08SVH 0.263
*Note: the compound similarity was calculated by RDKIT.